← Human Trials & Peer-Reviewed Studies
Effect of Vitamin D3 Supplementation During Pregnancy on Risk of Persistent Wheeze in the Offspring: A Randomized Clinical Trial.
Plain-language guide to PMID 26813208 (2016): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 708 participants.
Key Facts
- PMID
- 26813208
- Journal
- JAMA
- Year
- 2016
- Study type
- Randomized Controlled Trial
- Authors
- Chawes BL et al. (16 authors)
- DOI
- 10.1001/jama.2015.18318
- Registered trial
- NCT00856947
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.
Enrollment began March 2009 with a goal of 708 participants, but due to delayed ethical approval, only 623 women were recruited at 24 weeks of pregnancy.
Who Took Part
The abstract describes 708 participants taking part.
PubMed indexes the participants as infants, young children and adults, women only.
A double-blind, single-center, randomized clinical trial conducted within the Copenhagen Prospective Studies on Asthma in Childhood 2010 cohort.
Follow-up of the children (N = 581) was completed when the youngest child reached age 3 years in March 2014.
How the Study Was Run
In design terms this was a randomized, double-blind and placebo-controlled study.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
Neither the participants nor the staff measuring them knew who was on Vitamin D, K2, Magnesium and Zinc, so expectations could not easily colour the readings.
The comparison arm used a placebo, so changes seen with Vitamin D, K2, Magnesium and Zinc could be set against what happens without it.
What Was Measured
Topics PubMed links to this paper include Asthma, Cholecalciferol, Pregnancy Trimester, Third, Respiratory Sounds, Vitamin D and Vitamins.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 708 participants.
With several hundred people or more, it is a fairly large study for this kind of research.
Results are reported in around 8 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2016 (JAMA), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.